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Abstract
Background: Prompt access to effective treatment is central in the fight against malaria. However,
a variety of interlinked factors at household and health system level influence access to timely and
appropriate treatment and care. Furthermore, access may be influenced by global and national
health policies. As a consequence, many malaria episodes in highly endemic countries are not
treated appropriately.
Project: The ACCESS Programme aims at understanding and improving access to prompt and
effective malaria treatment and care in a rural Tanzanian setting. The programme's strategy is based
on a set of integrated interventions, including social marketing for improved care seeking at
community level as well as strengthening of quality of care at health facilities. This is complemented
by a project that aims to improve the performance of drug stores. The interventions are
accompanied by a comprehensive set of monitoring and evaluation activities measuring the
programme's performance and (health) impact. Baseline data demonstrated heterogeneity in the
availability of malaria treatment, unavailability of medicines and treatment providers in certain areas
as well as quality problems with regard to drugs and services.
Conclusion: The ACCESS Programme is a combination of multiple complementary interventions
with a strong evaluation component. With this approach, ACCESS aims to contribute to the
development of a more comprehensive access framework and to inform and support public health
professionals and policy-makers in the delivery of improved health services.
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Background
The impact of malaria on health and local economies in
sub-Saharan Africa is staggering. Between one and three
million people die each year, mostly young children
under five years of age. Deaths and illness contribute to a
vicious circle of ill-health and poverty [1,2]. In recent
years, the fight against malaria has gained an increased
level of attention from governments of affected African
states as well as from international donor agencies. Afri-
can heads of state agreed in the Abuja Declaration on a
concerted effort to reduce the burden of malaria on the
continent and endorsed the ambitious goal of the Roll
Back Malaria Partnership of halving the number of
malaria deaths by the year 2010 [3]. Among the malaria
control strategies promoted internationally and adopted
by most endemic African countries, prompt access to
effective treatment especially for young children and preg-
nant women features prominently [2].
The need for prompt and effective treatment to prevent
progression to severe disease and death essentially raises
two important issues: first, the choice of a safe and effica-
cious drug and second, questions of how to optimize
equitable access to rationally prescribed treatment.
In order to address the first point, artemisinin-based com-
bination therapies (ACT) have been advocated as treat-
ment of choice in Africa [4] in an effort to improve on
drug efficacy following the increasing failure rate of a
number of other drugs. Tanzania adopted this policy in
2004 and implemented it at the end of 2006 [5]. How-
ever, the choice of an efficacious drug does not necessarily
directly result in improved effectiveness, and issues
related to safety, use in pregnancy, and cost are also still
being discussed. Yet, it would go beyond the scope of this
paper to thoroughly debate all issues related to a specific
drug.
With regard to the second point, it is widely acknowl-
edged that access to quality treatment is insufficient in
many settings. The poorest people often have least access
to effective treatment [6] and the underlying causes of this
situation are increasingly debated. On a macro-level, the
discussion on access to treatment often focuses around
the development of new drugs [7] and global affordability
issues, including pricing and patenting of drugs. Interna-
tional initiatives, such as Medicines for Malaria Venture
(MMV) [8], are increasingly financing and speeding up
the development and introduction of new efficacious
antimalarials. At a local community level however, the sit-
uation is a lot more complex and availability and afforda-
bility of drugs are only few among a number of factors
influencing prompt and effective treatment [9,10]. In
many developing countries, weak health systems as well
as lack of equipment and qualified staff lead to incorrect
diagnosis and treatment [11,12]. Physical access may be
impeded by long distances to the nearest point of care,
inadequate logistics or inability to pay for secondary costs
such as transport [13]. Further, malaria is a common and
socially well accepted illness in endemic countries and its
potential severity is often underestimated. Insufficient
knowledge of the appropriate treatment or an under-
standing of the illness that differs from the bio-medical
explanation can lead to the use of alternative treatment
sources and non-adherence to recommended regimens
[14,15].
Several initiatives have attempted to address access ques-
tions on a local level, either by strengthening home-based
management [16], by improving the involvement of com-
mercial drug providers [17] or through a general improve-
ment of health system performance. Information and
education of caretakers and care providers has been useful
in improving malaria case management and compliance
at home and in drug selling shops [17-19]. Several models
for improving case-management in health facilities have
been tested and combined approaches were most likely to
have a (sustainable) impact [20]. In any case, considering
the complexity of the issues involved it seems obvious
that there is no such thing as a single "magic bullet"
approach to solve the problem. What is needed is a com-
prehensive concept addressing several of the access
dimensions, ranging from availability and affordability to
accessibility, acceptability and quality of care. This paper
presents a programme that was developed to understand
and improve comprehensively access to appropriate
malaria treatment in a highly malaria-endemic rural area
of south-eastern Tanzania.
The aim of the ACCESS Programme is to investigate fac-
tors influencing access to malaria treatment in rural Tan-
zania in order to develop a set of interventions addressing
the main obstacles to access. These interventions are then
thoroughly evaluated. The focus is on children below five
years of age and pregnant women, who are the most vul-
nerable groups in this holo-endemic setting in terms of
the detrimental consequences of malaria [21,22]. This
paper presents a general overview of the ACCESS Pro-
gramme, while future reports will provide detailed study
results of the major evaluation and monitoring compo-
nents.
Project description
Study area
The programme's intervention area comprises the two dis-
tricts of Kilombero and Ulanga in the south-east of Tanza-
nia (Figure 1). The Kilombero River separates the two
districts and forms the vast Kilombero Valley floodplain.
Large parts of this valley are flooded during the rainy sea-
son which usually lasts from November to May. The valleyMalaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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is delimited by the Udzungwa Mountains in the north and
the Mahenge Mountains in the south. Parts of Ulanga's
southern and south-eastern areas, as well as Kilombero's
extreme east are part of the Selous Game Reserve. The Kil-
ombero district is connected to the Tanzania-Zambia
highway through a mostly unpaved but well maintained
road. For vehicles the only connection to the Ulanga dis-
trict is made by a motorized ferry over the Kilombero
River.
In 2002, there were 517,000 people living in the 109 vil-
lages of the two districts. Ifakara, the administrative capi-
tal of Kilombero, is the major settlement in the valley with
a population of approximately 46,000. Ulanga's capital
Mahenge is smaller with 7,300 inhabitants [23]. In the
early 1970s, the national social engineering project to
build communal villages ("vijiji vya ujamaa") brought the
valley's scattered inhabitants to more organised village
centres along the edges of the valley [24]. Most people
there rely on subsistence farming for their livelihoods.
Labour intensive rice farming on distant fields in the
floodplain forces many families to move to their farming
sites (shamba in Kiswahili) during the cultivation period.
In the fields people stay in improvised "shamba huts" for
up to six or more months. Rice, maize and cassava are the
main cash crops. The main agricultural exports from both
districts are rice, timber, charcoal and some fish. Since the
1980s, an increasing number of nomadic Maasai and
Sukuma pastoralists had moved to the valley with large
cattle herds until a government directive ordered them in
April 2006 to move to other parts of the country or to
reduce their herds in order to preserve the Kilombero wet-
land ecosystem [25,26].
The climatic and ecological conditions in the floodplain
are favourable for mosquito breeding. Malaria transmis-
sion in the valley is high and perennial. Recent work has
confirmed entomological inoculation rates (EIR) of 350
infective bites per person per year, despite high mosquito
net usage rates of 75% (G. Killeen, personal communica-
tion). At the level of health services, malaria is the most
frequent diagnosis in outpatients in rural health facilities.
A number of malaria control interventions have been
tested and/or implemented in the area by the Ifakara
Health Research and Development Centre [27] in collab-
oration with the Swiss Tropical Institute [28]. The most
extensive operation was the large-scale introduction of
insecticide-treated nets (ITN) in the frame of the KINET
project [29]. Today, promotion of ITN use through social
marketing is ongoing in the frame of the national ITN pro-
gramme.
Monitoring and evaluation (M&E) of the ACCESS Pro-
gramme is carried out in the area of the local Demo-
graphic Surveillance System (DSS) [30]. The DSS serves as
a comprehensive epidemiological framework for studies
on the project's impact. In the absence of a vital registra-
tion, DSS field workers routinely record births, deaths,
migrations and socio-economic indicators for every
household in a defined geographical area of 2400
km2(Figure 1). Each household is visited every four
months. The area comprises 12 villages in Ulanga and 13
in Kilombero. In mid 2004, the total DSS population was
74,200 (Ulanga: 31,800; Kilombero: 42,400) in 17,050
households. The DSS does not include Ifakara town where
ACCESS M&E activities are also implemented.
Main interventions
ACCESS interventions apply two main approaches:
1. Creating demand for appropriate malaria diagnosis and
treatment in the community through a social marketing
approach.
2. Strengthening the supply of quality malaria case-man-
agement at health facilities and drug shops through train-
ing, quality management, improved supportive
supervision and new diagnostics.
The main areas of intervention are described below and
summarized in Figure 2 (status at the end of 2006). Activ-
ities may change in the future as experience is gathered
and analyzed by the programme's M&E activities.
Intervention area 1: Behaviour change campaigns for 
prompt and appropriate health care seeking
Sensitization of community leaders
As a first preparatory step in implementing community
activities, local community leaders (political and religious
leaders, leaders of social groups, non-governmental
Map of Kilombero and Ulanga districts with DSS area Figure 1
Map of Kilombero and Ulanga districts with DSS area.Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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organizations and other key opinion leaders) were
informed about ACCESS objectives and activities to gain
their support and collaboration. The meetings also pro-
vided space for participants to share their views and con-
cerns on programme-related issues.
Social marketing
A social marketing approach was chosen to increase
knowledge and awareness of malaria and to promote
prompt and appropriate treatment seeking from reliable
sources. The design of the behaviour change communica-
tion campaign was based on experiences from projects
such as KINET (Kilombero Net Project) [29,31], TEHIP
(Tanzania Essential Health Interventions Project) [32]
and IMPACT-Tz (Interdisciplinary Monitoring Project for
Antimalarial Combination Therapy in Tanzania), as well
as the national social marketing for ITNs and the results
from exploratory focus-group discussions. In the first year,
implementation was done in the DSS area and Ifakara
only, followed by a step-wise scaling-up to the other vil-
lages of Kilombero and Ulanga.
The main target audience of the campaign are mothers and
caretakers of children under five years of age and pregnant
women. However, other household members and the
general population are secondary audiences in order to
achieve homogeneity of understanding in the population.
Messages stress the importance of prompt recognition of
malaria symptoms and immediate correct treatment with
the recommended first-line drug (sulphadoxine-
pyrimethamine [SP] until end 2006). Health facilities and
licensed drug stores (pharmacies, part II drug stores [duka
la dawa baridi] and Accredited Drug Dispensing Outlets
[ADDO; duka la dawa muhimu]) are promoted as sources
of proper treatment and advice. Prevention methods, such
as the use of ITNs and Intermittent Preventive Treatment
in pregnancy (IPTp) are also advocated. Finally, one set of
messages highlights high fever with convulsions (locally
known as "degedege") as a sign of severe malaria that can
and should be treated at health facilities (rather than by
traditional healers) [14,31]. ACCESS messages are in line
with malaria-related messages on key family practices of
the community-based Integrated Management of Child-
hood Illness (IMCI) [33].
Communication channels and materials to disseminate
behaviour change messages were developed to reach a
poor rural population in an efficient and cost-effective
way. Road shows are the main vehicle for the campaign.
The platform of a truck is used as a mobile stage for a
health promotion team (Figure 3). The shows are divided
in four parts:
1. Dancing competition to attract a large audience
2. Comedies and role plays portraying appropriate treat-
ment seeking and consequences of delaying treatment
3. Public lecture on malaria transmission, signs and symp-
toms, dangers of malaria for young children and pregnant
women, and prevention and correct treatment
4. Cinema show featuring stories on prompt and effective
malaria treatment
Question-and-answer sessions at the end of each part
allow interaction with the audience and distribution of
promotion-materials (e.g. stickers, leaflets, T-shirts).
ACCESS road show with social marketing truck Figure 3
ACCESS road show with social marketing truck.
Timeline with main interventions and M&E activities Figure 2
Timeline with main interventions and M&E activities.
Area 2: Health facilities
Area 3: Drug shops
Health facility
Shop survey
Health impact
Legend: DSS = Demographic Surveillance System
QIRI = Quality Improvement and Recognition Initiative
ADDO = Accredited Drug-Dispensing Outlets
K & U = Kilombero and Ulanga districts
Comm. survey = Cross-sectional community survey
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Permanent billboards were erected in major villages along
the main road and posters affixed in public places (Figure
4). All materials carry campaign-related messages and the
ACCESS logo (Figure 5). Materials were locally designed
and pre-tested in the community.
Remote villages which are inaccessible with the truck are
reached by a small 4WD vehicle branded with behaviour
change slogans. It transports a mobile video unit and
rooftop speakers to air behaviour change radio spots.
Special campaigns in Mother and Child Health (MCH) clinics
Special campaigns were implemented in MCH clinics.
They were targeted especially at pregnant women and
mothers of young children who may not attend road
shows if they overlap with the women's duties in the
household. During special sessions, ACCESS health pro-
moters and MCH clinic staff informed mothers on
malaria, its prevention and its proper treatment. The ben-
efits of malaria prevention using ITNs and IPTp were par-
ticularly emphasized.
Improved access for households spending the cultivation period away 
from home: The shamba component
The main farming season, when many families stay in
their field-huts, overlaps with the high malaria transmis-
sion season. Furthermore it represents a period of high
vulnerability as it coincides with peak food insecurity,
labour stress and difficult access to health services, family
support and child care time. A study was undertaken
within the programme to investigate the specific risks
posed by staying in the fields. Results from this study may
lead to the design of a "shamba intervention" if specific
measures are deemed necessary.
Intervention area 2: Improved quality of care in health 
facilities
Trustworthy health care services of good quality are a core
element for the delivery of effective diagnosis and treat-
ment for malaria. As a result of the social marketing, the
demand for quality services is expected to increase. In
order to meet this demand, the health facility staff must be
in the position and willing to deliver a good quality of
care. The programme aims to improve quality of care with
a focus on the following areas:
• Correct diagnosis through the proper use of the IMCI
algorithm or with improved laboratory diagnosis
￿ Rational prescription of antimalarials, antipyretics and
other drugs
￿ Appropriate advice on prescribed treatment and malaria
prevention
Key activities of this component include initial refresher
training for health facility staff on malaria treatment, fol-
lowed by the strengthening of routine supportive supervi-
sion and the implementation of a quality management
scheme in all health facilities. Training was based on IMCI
algorithms for diagnosis and treatment which have
proven (cost-)effective in improving quality and efficiency
of child health care in rural Tanzania [34]. A protocol for
the refresher training was developed in close collabora-
tion with the Council Health Management Teams
ACCESS Programme logo Figure 5
ACCESS Programme logo.
ACCESS billboard promoting prompt and correct treatment Figure 4
ACCESS billboard promoting prompt and correct treatment.Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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(CHMT) of Kilombero and Ulanga. The training was tar-
geted at clinical staff, lab technicians, and medical aids of
public and private health facilities. It was carried out by
the CHMT, appointed trainers and ACCESS staff with
financial resources from the district and ACCESS.
The follow-up with routine supportive supervision will
not focus on malaria only. It is planned to implement a
comprehensive package of activities aiming at improving
performance management for improvement of quality of
services delivery: The Quality Improvement and Recogni-
tion Initiative (QIRI) was originally developed by USAID
and adapted and implemented in Tanzania by the Minis-
try of Health (MOH) to improve the quality of reproduc-
tive and child health services within the 2001–2005
USAID-Tanzania programme support [35]. Between 2003
and 2006, the United Nations Population Fund (UNFPA)
Tanzania through the European Union/UNFPA Sexual
and Reproductive Health programme supported the
MOH for further QIRI expansion in Tanzania [36].
QIRI offers an integrated approach for the evaluation of
quality of care combined with a strategy to establish the
root causes of performance gaps and to develop imple-
mentable strategies to address them. A central element of
this component is capacity building for joint supportive
supervision and quality management, conducted by the
regional and district health management teams together
with community representatives. It is the aim of the pro-
gramme to integrate quality management into the health
supervision activities in the decentralized health system.
Acknowledging the importance of patient-provider rela-
tionships and trust in health care [37,38], QIRI is
designed to pay particular attention to the patients' per-
ception of the health services.
In most malaria endemic areas, diagnosis of malaria relies
mainly on clinical signs and symptoms, especially in low
level health facilities. In Tanzania, only hospitals and
health centres are expected to have the possibility of per-
forming microscopy for malaria diagnosis [39], while dis-
pensaries rely on a syndromic IMCI approach [40]. In the
programme area, the malaria-attributable fraction esti-
mated using the method of Smith et al. [41] showed that
only 40% of all fever episodes were likely to be due to
malaria (S. P. Kachur and S. Abdulla, personal communi-
cation). Absence of lab diagnosis may result in misdiag-
noses and irrational drug-prescription [11,42].
A promising alternative to microscopy are rapid diagnos-
tic tests (RDT) based on the detection of Plasmodium anti-
gens. However, there is little experience with RDTs in sub-
Saharan Africa although they are widely used in Asia and
Latin America [43]. ACCESS plans to introduce RDTs in
three dispensaries, so far lacking diagnostic tools for
malaria. To compare the feasibility and value of RDTs ver-
sus conventional diagnostics, high quality microscopy
will be assured in two health centres. The efficacy, effec-
tiveness and cost-effectiveness of this intervention will be
evaluated.
Intervention area 3: Improved malaria case management 
in drug selling shops
Self-treatment at home is often the first and quickest
response to a malaria episode [16,44,45]. In many set-
tings, the private drug retail sector plays an important role
in providing drugs for home-based management of fever
or malaria. On the other hand, drug shops often leave
patients with sub-standard malaria drugs and poor pre-
scribing practices [46], leading to ineffective treatment
and increasing drug resistance. Experience in Kenya
showed that training private drug retailers can considera-
bly improve the services they offer [17]. However, Tanza-
nian drug regulations do not allow general shops to sell
the first-line antimalarial drugs (SP; or ACT since end
2006), even though the national malaria control strategy
mentions explicitly the availability of antimalarials on
household-level [5,47,48].
As a result of this ambiguous policy, the initial plan to
train general shop keepers had to be withdrawn and other
avenues explored. As an alternative, the programme sup-
ports the introduction of Accredited Drug Dispensing
Outlets (ADDO; duka la dawa muhimu in Kiswahili) in the
two districts. The ADDO project is being implemented by
the Tanzania Food and Drugs Authority (TFDA) and Man-
agement Sciences for Health (MSH). It aims to improve
access to affordable, quality medicines and pharmaceuti-
cal services in drug retail outlets in rural and peri-urban
areas where there are few or no registered pharmacies
[49,50]. The main components of the ADDO project are
activities to change the behaviour of shop owners and dis-
pensing staff through the provision of education, incen-
tives and regulatory coercion. It also entails efforts to
positively affect client demand and expectation of quality
products and services.
ADDOs are allowed to dispense a limited range of pre-
scription-only medicines that are found on the national
essential drugs list. Ideally at least one ACT should be
available through this channel, most logically the one rec-
ommended as first-line treatment in the country (cur-
rently artemether/lumefantrine [ALu], brand name
Coartem®). For the districts of Kilombero and Ulanga,
ACCESS could successfully negotiate the introduction of
highly subsidized ALu in ADDOs. The ACCESS social
marketing campaign promotes ADDOs as source of qual-
ity malaria treatment.Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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Monitoring and evaluation
The M&E activities of ACCESS are based on three key com-
ponents: (1) A semi-quantitative analysis aiming at a bet-
ter understanding of factors influencing access to malaria
treatment in order to develop an improved access frame-
work, (2) process monitoring in order to understand how
interventions operate, and (3) a thorough evaluation of
the programme's impact on treatment seeking, quality of
case-management and most importantly on the health of
the population. An overview of the different evaluation
activities in relation to key work areas is given in Table 1.
Overall and health impact evaluation is based on a plau-
sibility assessment of the programme's impact within a
before-after design, i.e. a historical control group [51,52].
In an attempt to control for possible confounders, all
other malaria control activities in both districts as well as
other relevant parameters such as temperature and rainfall
are closely monitored. Longitudinal data will also be com-
pared to trends observed in Demographic and Health Sur-
veys (DHS). A basic assumption is that the malaria
transmission and other relevant epidemiological parame-
ters remain largely unchanged during the period of obser-
vation with the exception of the factors that are monitored
in the frame of the programme.
Health impact assessment through the DSS
The health impact assessment will be based on data col-
lected through the DSS. The main outcome indicators are:
overall and malaria-specific mortality, reported fever inci-
dence rates in children and adults, as well as reported
degedege (convulsion) rates in children. Furthermore, the
DSS will be used as a sampling frame for representative
community-based epidemiological studies.
Cause-specific mortality is calculated on the basis of "ver-
bal autopsies". Since 2002, specially-trained DSS supervi-
sors elicit information on causes of deaths by interviewing
bereaved relatives about the circumstances of the death,
the signs and symptoms observed during the illness lead-
ing to the death, and the action taken. This information is
coded to give likely causes of death in broad categories.
The socio-economic status (SES) of households is assessed
once a year on the basis of a list of household assets. This
allows the results of DSS data and other community-
based studies to be stratified by wealth quintiles, which is
essential in order to consider equity dimensions in the
analysis. The aim of the ACCESS Programme is to contrib-
ute to an equitable reduction of (malaria-related) mortal-
ity.
Exploratory focus-group discussions
Initial exploratory focus-group discussions (FGD) with
parents and caretakers of young children informed the
programme on knowledge, attitudes and practices related
to malaria treatment. A total of 88 people participated in
the ten FGDs, four of which were done with men, six with
women. Main issues that came up during FGDs are listed
in the results section.
Community-based surveys on treatment-seeking for fever
Repeated cross-sectional community surveys are the pro-
gramme's main tool to assess changes in care-seeking
behaviour for fever episodes. Explanatory Model Inter-
view Catalogues (EMIC) are used to simultaneously col-
lect cultural epidemiological qualitative and quantitative
data on patterns of distress, perceived causes and help
seeking [53]. A baseline survey was carried out in 2004 in
the DSS villages and Ifakara town. Interviews were done
with 80 caretakers of children and with 68 adults who
experienced a fever episode in the preceding two weeks.
Only people who had recovered from their illness the day
of the interview were included while others were advised
to consult a health professional. The same methodology
will be applied in follow-up surveys every two years. It is
expected that over the course of the programme, the
number of appropriately treated fever episodes will
increase with more people shifting to qualified care pro-
viders.
The EMIC was also used in a longitudinal study exploring
treatment seeking during the cultivation period, when
many people live in their shamba huts. About 100 house-
hold owning a temporary home in the fields were ran-
domly sampled from DSS villages and followed up during
one farming season. Each household was visited once a
month by a team of field workers who recorded each fam-
ily member's stay in the field, the occurrence of fever epi-
sodes and other indicators. In case of a fever episode in the
preceding two weeks, an EMIC interview was conducted.
A household survey in a larger sample of 3'654 persons
carried out in 2006 by a partner project (IMPACT-Tz) in
the study area was used to assess uptake of social market-
ing messages by the population.
Case-control study on degedege
A case-control study on degedege (convulsions) was nested
in the DSS data collection. The study compares treatment
seeking patterns and self-observed signs and symptoms
for fatal ("cases") and non-fatal ("controls") degedege epi-
sodes in children. Degedege has commonly been treated
by traditional healers rather than with modern medicine
[14]. However, this may have changed over time. EMIC
questionnaires and extended verbal autopsies (VA) were
used as data collection tools for non-fatal and fatal cases
respectively. Non-fatal degedege cases were reported rou-
tinely by DSS field-workers. A random sample was then
followed up every two weeks for an EMIC interview. ThisM
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Table 1: ACCESS Programme components and corresponding indicators for evaluation (refer to main text for details)
Indicator Sources of verification/study 
methods
Sample Timing
Intervention area 1: Behaviour change campaign
(Expected results: Improved health care seeking behaviour for all fever/malaria episodes)
Proportion of episodes treated according to national guidelines within 
24 h Treatment-shift to qualified providers
Cross-sectional community surveys (fever 
and degedege) with EMIC tool
Random sample of households Repeated (baseline, mid-term, end)
DSS (morbidity) and health facility 
attendance
DSS area, all health facilities Continuous
Equitable access to appropriate treatment DSS SES data DSS area, all health facilities Continuous
Intervention area 2: Quality of care in health facilities (Expected results: Improved quality of care in health facilities, especially malaria case-management, incl. diagnosis, prescription, treatment, advice, 
compliance)
Proportion of episodes receiving correct prescription and appropriate 
advice Patient's satisfaction with services
Quality of care surveys in health facilities Sample of health facilities Repeated (baseline, mid-term, end)
QIRI All health facilities Continuous
Intervention area 3: Malaria case-management in shops
(Expected results: Improved quality of malaria case-management in drug selling shop, such as retailing practices, prescriptions, advice)
Proportion of episodes receiving correct prescription and appropriate 
advice
Mystery shoppers All drug stores and random sample of general 
shops
Annually
Shop-keepers' knowledge of malaria symptoms, correct treatment and 
advice Availability of first- and second-line antimalarial drugs
Cross-sectional surveys in shops stocking 
drugs
All retailers stocking drugs Annually
Shamba component
(Expected results: Coverage of appropriate malaria treatment and care services extended to underserved areas, incl. shamba households)
Proportion of households within 5 km range of qualified provider DSS GPS data All households, health facilities and shops stocking 
drugs
Repeated
Proportion of episodes in underserved areas/poor households/shamba 
houses receiving correct treatment
Cross-sectional community surveys (fever 
and degedege), DSS SES data
Random sample of households Repeated (baseline, mid-term, end)
Health impact
(Expected results: Reduction of malaria related morbidity and mortality, especially in children under five and pregnant women)
Proportion of malaria-related deaths DSS mortality data: overall and cause-
specific.
All households Continuous
Number of fever episodes. DSS fever incidence All households Continuous
Additional studies
Understanding and perception of malaria, its treatment and prevention Focus-group discussions 10 groups of caretakers of children under five 
years in Ifakara and DSS
Once prior to interventions
Risk factors for fatal outcome of degedege Case-control study Cases:degedege-related child deaths in DSS 
Controls: recovered degedege cases
Once
Vulnerability and coping strategies of households during the farming 
season; movement patterns and health seeking
Cohort study with shamba households Random sample of households with field (shamba) 
house
Once
Antimalarial drug quality Cross-sectional survey All drug stocking retailers and health facilities Once
EMIC = Explanatory Model Interview Catalogue. DSS = Demographic Surveillance System. SES = Socio-economic Status. QIRI = Quality Improvement and Recognition Initiative. GPS = Geographic Positioning 
System.Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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study is expected to provide information on observed
"danger signs" and factors related to treatment seeking
and leading to death or recovery. It will add an important
aspect to the existing knowledge on management of fatal
malaria including cases of convulsions as described by de
Savigny et al. [54].
Quality of care at health facilities
Initial assessment of quality of care is based on yearly sur-
veys in a sample of public and private/mission health
facilities. Tools were adapted from the multi-country eval-
uation of IMCI [55]. Activities include patient-provider
observations, as well as staff and patient exit interviews.
Furthermore, laboratory equipment is checked for func-
tionality and drug stocks are recorded. With the imple-
mentation of the QIRI tools for supportive supervision in
2007 (as outlined above), evaluation of quality of care
will be done largely through QIRI which will assess qual-
ity of care twice annually in all health facilities. Results
will then feed directly into activities aimed at improving
quality of care. It is expected that the programme's inter-
ventions will lead to improved malaria case-management
and more rational prescription of antimalarial drugs.
Health facility attendance and availability of antimalarials
Health facility attendance data and frequency of specific
diagnoses are routinely recorded by health facility staff for
the health management information system (HMIS). This
information is collected bi-monthly from all private and
public health facilities in Ifakara (one public, one private)
and the DSS area (10 public, five private) by ACCESS staff.
Together with the DSS fever incidence data which pro-
vides a community estimate, this information will allow
to calculate the proportion of fever cases diagnosed as
malaria and treated at health facilities. This proportion is
expected to rise over the course of the project. In the frame
of this activity, availability of antimalarial drugs is moni-
tored in all health facilities in the DSS.
Quality of antimalarial drugs
In 2005, a study was designed to get an overview of the
quality of antimalarials available in the programme's
study area. For this purpose, all antimalarial selling points
in the 25 DSS villages as well as in Ifakara were visited,
including general shops, drug stores, pharmacies and
health facilities. Samples of SP, amodiaquine and quinine
products were purchased and the amount of active ingre-
dient quantified according to the United States Pharmaco-
poeia (USP 24) using previously set up high-performance
liquid chromatography (HPLC) methods [56,57]. In
accordance with USP standards, products with less than
90% and more than 110% of the labelled amount of
active ingredient were counted as failures.
Quality of services at shops selling drugs
Based on the methodology developed by Goodman et al.
[58] for monitoring antimalarial drug availability, the
DSS villages and Ifakara are searched annually for drug-
selling shops and the shopkeepers are interviewed. A
structured questionnaire is used to record current drug
stock and shopkeeper's knowledge of malaria treatment.
Simultaneously, the shop's locations are recorded with
hand-held GPS devices. This approach allows monitoring
the shopkeepers' knowledge of malaria treatment, the
services and drugs offered, as well as the coverage of shops
stocking drugs as a proxy for availability and accessibility.
In a second approach, "mystery shoppers" (simulated cli-
ents) buy drugs in local commercial outlets. For this pur-
pose, local villagers are hired and instructed to go to a
nearby shop and ask for treatment for fever/malaria on
the basis of standard case scenarios.
Costing of implementation activities
A financial analysis of the intervention costs will be per-
formed after the interventions have been running for at
least two years. A cost-effectiveness analysis will combine
measures of effectiveness (see under health impact assess-
ment) and financial costs. For this purpose, a clear distinc-
tion is maintained at the level of IHRDC administration
between the cost related to interventions and the cost
related to research, monitoring and evaluation.
Assessing the impact of the introduction of Artemether-Lumefantrine
Tools developed by the ACCESS Programme will be used
to monitor prospectively the health impact of the switch
in first-line treatment for malaria from SP to Artemether-
Lumefantrine. This assessment will be done in the frame
of a related but separate project, called "Artemether-
Lumefantrine in vulnerable patients – exploring health
impact" (ALIVE). It will include monitoring changes in
child mortality trends as well as annual community-based
cross-sectional studies and an in-depth compliance study
in 500 children.
Progress and results to date
Community leaders' sensitization and social marketing
Community activities started with the sensitization of
community leaders followed by road shows in the 25 vil-
lages of the DSS area and in Ifakara town in 2004. The
2005 round covered an additional 56 non-DSS villages in
both districts (59%) and by the end of 2006, a total of 114
(79%) villages were reached with both activities (Figure
6). On average 40 community leaders per village (90% of
the invited) attended the sensitization meetings (total of
over 5,000 in three years) and shared their views and con-
cerns, such as:Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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"We have seen different health care providers prescribing
malaria treatment to patients differently. Some prescribe
quinine alone, or SP alone and sometimes quinine and
later on SP. We get confused! Which is the appropriate
treatment for malaria?" (Participant, Idete village)
"Children, wives and sometimes relatives of the drug shop
owners sell in some of the drug shops. We know these peo-
ple; they have no formal training, only instructions. It is
dangerous." (Participant, Igima village).
Road shows were generally very well attended. Turn-up
varied considerably depending on the size of the village,
ranging from few hundred to a few thousand people dur-
ing big shows such as in Ifakara. In a cross-sectional survey
done in 2006 in the DSS area, 39% (95% CI 37.2 to 40.4)
of the people mentioned that they had attended an
ACCESS road show. Men were 2.2 (95% CI 1.9 to 2.5)
times more likely to have attended such a show than
women (P < 0.001) and younger people were more often
exposed than older (Figure 7). Further, many people had
been in contact with or seen promotion materials such as
t-shirts and caps (48%), a vehicle displaying ACCESS slo-
gans (46%), or billboards (35%). Community leaders'
sensitization meetings reached 16% of the interviewed.
MCH campaigns
So far, 18 special sessions for pregnant women have been
carried out in MCH clinics in the DSS area, one in Ifakara
and 28 in non-DSS villages of both districts. In the DSS
alone, about 4,700 mothers attended the sessions, repre-
senting approximately 28% of all women in reproductive
age.
Health facility intervention
Between November 2004 and April 2005, several refresher
training sessions were organised in collaboration with the
CHMTs of Kilombero and Ulanga. In Ulanga, 100 (89%
of total) clinicians, nurses, medical aids and technicians
from rural dispensaries and health centres attended the
trainings. In Kilombero, 39 (93% of total) clinicians were
trained. The tools for supportive supervision and quality
management are currently being developed.
Accredited Drug Dispensing Outlets
The ADDO programme was targeted at the 32 existing
drug stores in Ulanga and 93 in Kilombero District
[59,60]. After a preparatory phase of training shop owners
and dispensers, setting up or renovating shop infrastruc-
ture and a licensing procedure, ADDOs were launched in
Ulanga in May 2006 and in Kilombero in July 2006. By
end 2006, there were 114 ADDOs operational in Kilomb-
ero district and 44 in Ulanga (R. Mbwasi, personal com-
munication).
Monitoring & evaluation
2004 baseline population of the DSS area was 74,200
people, with a crude death rate of 11.6/1,000 people-years
observed (PYO). The probability of dying before reaching
the age of one year is 63.9/1,000 PYO and before the age
of five 109.5/1,000 PYO. The risk of a fever episode
("homa kali") in the two weeks preceding the interview
was estimated at 144/1,000 people between May and
August and 119/1,000 between September and Decem-
ber. The risk of a degedege episode in the previous two
weeks was 12/1,000 people between September and
December. Mosquito net coverage during the main culti-
vation period (and peak malaria transmission season)
Coverage of social marketing campaign in 25 DSS villages:  proportion of the population that has attended an ACCESS  road show by age group Figure 7
Coverage of social marketing campaign in 25 DSS villages: 
proportion of the population that has attended an ACCESS 
road show by age group.
Map of the study area showing intervention areas 2004 –  2006 Figure 6
Map of the study area showing intervention areas 2004 – 
2006.Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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was high in the field huts, with 93–100% of households
having a net in their huts and an average of over 97% of
people in the huts sleeping under a net (treated or not) the
night preceding the interview [61].
There were seven health facilities in the 13 Kilombero DSS
villages and seven in the 12 Ulanga DSS villages in 2004
(one facility per 5,300 people). By 2006, one private dis-
pensary had closed down in Kilombero and a new public
dispensary had been opened in Ulanga. The St. Francis
Designated District Hospital in Ifakara serves as main
referral hospital for all villages in the DSS. On average per
month, each of these facilities recorded 240 out-patient
visits due to malaria, over 60% of which were children
under five. Malaria accounted for 52% of all out-patient
visits of children under five and for 37% of all patients
over the age of five (Figure 8). In addition to health facil-
ities, there were 30 shops in Kilombero DSS, 13 in Ulanga
DSS and 14 in Ifakara offering antimalarial drugs [47].
Focus-group discussions revealed mainly the following
malaria-related concerns:
￿ SP had a bad reputation in Tanzania following media
coverage on severe side-effects (Stevens-Johnson syn-
drome) at the time of its introduction as first-line treat-
ment in 2001[62]. Some people feared SP although they
or their children had never experienced severe side-effects,
which are known to be rare [63]. People were confused
about different SP brand names.
￿ Modern medical treatment was preferred over tradi-
tional medicine and children were treated more quickly
than adults. Drug shops were often more conveniently
reachable and adults would often buy paracetamol from a
shop as first treatment for a fever episode.
￿ A majority of the people failed to resort to sources of
treatment that they otherwise would prefer – such as a
hospital. Factors such as cost, absence of trusted medical
professionals, unavailability of diagnostic instruments,
long waiting time, and distance were mentioned as
important obstacles.
These findings, together with national treatment guide-
lines and information from other projects and surveys
were used as basis for developing the behaviour change
campaign.
Quality tests of antimalarials (SP, amodiaquine and qui-
nine) purchased from health facilities and shops in 2005
confirmed the existence of sub-standard drugs in the study
area. In total 25% of the collected tablet samples did not
meet the USP specifications for the amount of active
ingredient and were mostly under-dosed. 12% of them
contained only minimal amounts of active ingredient.
Average monthly out-patients attendance at 16 health facilities in the DSS and Ifakara in 2004 (ARI = Acute Respiratory Infec- tions) Figure 8
Average monthly out-patients attendance at 16 health facilities in the DSS and Ifakara in 2004 (ARI = Acute Respiratory Infec-
tions).Malaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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Overall, 24% of the collected SP tablets and 40% of the
quinine sulphate tablets were sub-standard. All amodi-
aquine tablets and quinine injections contained the
labelled amount of active ingredient. Sub-standard drugs
were found mainly at general and drug shop level and
mostly originated from Tanzania and India [57].
Discussion and conclusion
In order to develop and validate a generic framework on
issues related to access to treatment [64], the ACCESS Pro-
gramme took malaria as an empirical case study. Of
course, access issues are also pressing with regard to most
other high-burden or neglected diseases in developing
countries. By focusing on malaria we chose a poverty-
related disease that affects large parts of sub-Saharan
Africa in terms of both, disease and economic develop-
ment, at a time when funding for its control is more read-
ily available than ever before [65].
The Kilombero Valley is an area for which the malaria sit-
uation has been particularly well described thanks to
numerous research activities [66-69]. The preventive use
of insecticide-treated mosquito nets has been advocated
through the large social-marketing of the KINET project
between 1997 and 1999. It resulted in high levels of ITN
ownership and use [29,70]. However, access to prompt
and appropriate treatment is still poor. A baseline study in
the frame of this programme found that only 14% of
young children received an effective antimalarial in the
correct dose on the day of illness onset [71]. The aim is,
therefore, to expand the successful approach chosen for
ITNs to the crucial issue of access to treatment. The main
target groups of the interventions are those most at risk in
holo-endemic areas such as the Kilombero Valley: young
children and pregnant women [21,22,72].
Interventions to improve the complex issue of access to
malaria treatment are more likely to be successful if sev-
eral working approaches are combined. Social marketing
applies concepts and techniques used in commercial mar-
keting to prompt behaviour change that benefits the target
group [73]. In recent years, it has become increasingly
popular in health promotion where it has been proven
effective e.g. in promoting the use of ITNs and reducing
child mortality [70]. However, care has to be taken that
men and women profit equally from the approach – a
challenge that has to be tackled by the programme. In the
frame of ACCESS, the marketed "product" is the knowl-
edge and awareness of malaria and the concept of treating
a malaria episode appropriately. The "price" to be paid by
the community is the adoption of the desired care-seeking
and preventive behaviour. However, inducement of
behaviour change alone is not sufficient; health services
which are acceptable and of good quality must be availa-
ble. Hence, the behaviour change campaign is also a way
of empowering the community to demand for good qual-
ity health care. Activities to improve quality of health serv-
ices become central components of the programme.
The major providers of malaria treatment services remain
health workers. Their practices are influenced by a variety
of factors and environments [20]. The Integrated Manage-
ment of Childhood Illness (IMCI) strategy adopted by
Tanzania is an effective step to improve health worker per-
formance leading to a reduction in child mortality [74]
and out-of-pocket expenditures by patients [75]. How-
ever, health systems often fail to implement effective
guidelines in a sustainable way [76]. The challenge there-
fore remains to assure adherence to IMCI guidelines and
to address factors not directly related to case-management
(e.g. motivation or job satisfaction). Multi-faceted
approaches including supervision and strengthening of
district-level health management are more likely to
improve performance [20]. The ACCESS Programme
therefore combines training and information with the
implementation of a quality-improvement process
including strengthening the supportive supervision capac-
ity of the district health management team.
As an alternative to formal health services, antimalarials
can be obtained from the commercial sector. Drug shops
and general stores are the most important alternative
treatment sources for malaria in the study area [58,77]. In
an attempt to ensure quality of services, antimalarial
drugs sales have recently been banned in general shops.
With no alternative sources replacing general shops this
policy resulted in a decreased availability of antimalarials
in the study area [47]. An alternative approach which has
worked well in Kenya would be training of drug vendors
[17]. However, current Tanzanian legislation does not
allow the selling of antimalarials in general shops. Conse-
quently, any national strategy has to focus on improving
the performance of drug stores and their dissemination to
underserved areas through the ADDO project.
For the impact evaluation of ACCESS, a plausibility design
had to be adopted [51]. Identifying a comparable place as
control area would not have been possible and randomi-
zation of different areas for intervention would not be fea-
sible within the frame of this programme. Supporting
evidence for causally linking an observed impact with the
programme's interventions will be obtained through the
collection of multiple indicators on intervention delivery,
coverage and potential confounders. While the limits of
such a design in establishing a causal link are obvious and
well known, it needs to be recognized that any large-scale
implementation goes through an iterative process of
measuring progress and impact while continuously adapt-
ing and improving the process. Consequently, the inter-
pretation of results has to take into account contextualMalaria Journal 2007, 6:83 http://www.malariajournal.com/content/6/1/83
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changes and external influences. Data from other DSS
sites and DHS in Tanzania will be of particular impor-
tance in interpreting mortality data and putting them into
perspective.
Baseline data demonstrated heterogeneity in the availabil-
ity of treatment sources, unavailability of medicines and
providers and serious quality problems with regard to
drugs and services. This supports the basic assumption
that there are several inter-linked factors influencing
access to effective malaria treatment.
The comparative advantage of the ACCESS Programme is
its combination of multiple interventions on different lev-
els of the health system, including a strong evaluation and
research component. With this approach, the programme
also aims to contribute to the wider debate on access to
appropriate health care in developing countries. Based on
Penchansky and Thomas' [78] understanding of "access"
as the degree of "fit" between the health system and its
users, the ACCESS Programme aims at developing a more
comprehensive access framework [64]. This can then
inform and support public health professionals and pol-
icy-makers in the delivery of improved health services,
ideally leading to better health and well-being.
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